Stock Research for GWPRF

GWPRF

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

GWPRF Stock Chart & Research Data

The GWPRF chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the GWPRF chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


GWPRF Due diligence Resources & Stock Charts

The GWPRF stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View GWPRF Detailed Price Forecast - CNN Money CNN View GWPRF Detailed Summary - Google Finance
Yahoo View GWPRF Detailed Summary - Yahoo! Finance Zacks View GWPRF Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View GWPRF Trends & Analysis - Trade-Ideas Barrons View GWPRF Major Holders - Barrons
NASDAQ View GWPRF Call Transcripts - NASDAQ Seeking View GWPRF Breaking News & Analysis - Seeking Alpha
Spotlight View GWPRF Annual Report - CompanySpotlight.com OTC Report View GWPRF OTC Short Report - OTCShortReport.com
TradeKing View GWPRF Fundamentals - TradeKing Charts View GWPRF SEC Filings - Bar Chart
WSJ View Historical Prices for GWPRF - The WSJ Morningstar View Performance/Total Return for GWPRF - Morningstar
MarketWatch View the Analyst Estimates for GWPRF - MarketWatch CNBC View the Earnings History for GWPRF - CNBC
StockMarketWatch View the GWPRF Earnings - StockMarketWatch MacroAxis View GWPRF Buy or Sell Recommendations - MacroAxis
Bullish View the GWPRF Bullish Patterns - American Bulls Short Pains View GWPRF Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View GWPRF Stock Mentions - StockTwits PennyStocks View GWPRF Stock Mentions - PennyStockTweets
Twitter View GWPRF Stock Mentions - Twitter Invest Hub View GWPRF Investment Forum News - Investor Hub
Yahoo View GWPRF Stock Mentions - Yahoo! Message Board Seeking Alpha View GWPRF Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for GWPRF - SECform4.com Insider Cow View Insider Transactions for GWPRF - Insider Cow
CNBC View GWPRF Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for GWPRF - OTC Markets
Yahoo View Insider Transactions for GWPRF - Yahoo! Finance NASDAQ View Institutional Holdings for GWPRF - NASDAQ


Stock Charts

FinViz View GWPRF Stock Insight & Charts - FinViz.com StockCharts View GWPRF Investment Charts - StockCharts.com
BarChart View GWPRF Stock Overview & Charts - BarChart Trading View View GWPRF User Generated Charts - Trading View




Latest Financial News for GWPRF


Monteverde & Associates PC Filed A Class Action Lawsuit On Behalf Of Shareholders Of GW Pharmaceuticals, PLC In The Southern District Of California
Posted on Friday June 04, 2021

Notice is hereby given that Monteverde & Associates PC has filed a class action lawsuit in the United States District Court for the Southern District of California, Ziegler v. GW Pharmaceuticals, PLC et al, Docket No. 3:21-cv-01019, on behalf of holders of American Depositary Shares of GW Pharmaceuticals, PLC, ("GW" or the "Company") (Nasdaq: GWPH) who held GW securities as of the record date, March 10, 2021 (the "Class Period"), and have been harmed by GW's and its board of directors' alleged v


New Strong Sell Stocks for May 6th
Posted on Thursday May 06, 2021

OYST, CDAY, GWPH, HRTG, and NATI have been added to the Zacks Rank #5 (Strong Sell) List on May 6, 2021


Jazz Pharmaceuticals' Acquisition of GW Pharmaceuticals Closes
Posted on Wednesday May 05, 2021

Jazz Pharmaceuticals (NASDAQ: JAZZ) and GW Pharmaceuticals are now under the same corporate roof. The two companies announced Wednesday that Jazz's acquisition of GW has been completed. In the companies' joint press release, Jazz CEO Bruce Cozadd was quoted as saying that the closing "mark[s] a transformative milestone in creating an innovative, high-growth, global biopharma leader in neuroscience with a worldwide commercial and operational footprint."


Jazz Pharma (JAZZ) Q1 Earnings Beat, Sales Miss, Stock Down
Posted on Wednesday May 05, 2021

Jazz Pharmaceuticals (JAZZ) reports mixed first-quarter 2021 results as earnings beat estimates while sales miss the same. Shares down


Stock Market & Investing Books

Enter a stock symbol to view the stock details.